Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | N/A | -5,155 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 4 |
| Other Working Capital | N/A | N/A | N/A | N/A | -363 |
| Other Operating Activity | 0 | 0 | 0 | 0 | -2,266 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $-7,780 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 0 | -299 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-299 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,068 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3,988 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $5,056 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -5 |
| Beginning Cash Position | N/A | N/A | N/A | N/A | 3,475 |
| End Cash Position | N/A | N/A | N/A | N/A | 447 |
| Net Cash Flow | $N/A | $N/A | $N/A | $N/A | $-3,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | -7,780 |
| Free Cash Flow | 0 | 0 | 0 | 0 | -7,780 |